These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24980044)

  • 1. Dose-volume response in acute dysphagia toxicity: Validating QUANTEC recommendations into clinical practice for head and neck radiotherapy.
    Anderson NJ; Wada M; Schneider-Kolsky M; Rolfo M; Joon DL; Khoo V
    Acta Oncol; 2014 Oct; 53(10):1305-11. PubMed ID: 24980044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I study of dose-escalated chemoradiation with accelerated intensity modulated radiotherapy in locally advanced head and neck cancer.
    Guerrero Urbano T; Clark CH; Hansen VN; Adams EJ; A'Hern R; Miles EA; McNair H; Bidmead M; Warrington AP; Dearnaley DP; Harrington KJ; Nutting CM
    Radiother Oncol; 2007 Oct; 85(1):36-41. PubMed ID: 17709149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparing the larynx and esophageal inlet expedites feeding tube removal in patients with stage III-IV oropharyngeal squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Amin N; Reddy K; Westerly D; Raben D; DeWitt P; Chen C
    Laryngoscope; 2012 Dec; 122(12):2736-42. PubMed ID: 22991101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
    Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
    Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D; Sia M; Lockwood G; Moseley D; Rosewall T; Bayley A; Bristow R; Chung P; Ménard C; Milosevic M; Warde P; Catton C
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e415-21. PubMed ID: 21477939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy.
    Bhide SA; Gulliford S; Fowler J; Rosenfelder N; Newbold K; Harrington KJ; Nutting CM
    Radiother Oncol; 2010 Oct; 97(1):86-91. PubMed ID: 20826031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Favourable impact of intensity-modulated radiation therapy on chronic dysphagia in patients with head and neck cancer.
    Anand AK; Chaudhoory AR; Shukla A; Negi PS; Sinha SN; Babu AA; Munjal RK; Dewan AK; Kumar K; Doval DC; Vaid AK
    Br J Radiol; 2008 Nov; 81(971):865-71. PubMed ID: 18941046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment.
    Mazzola R; Ricchetti F; Fiorentino A; Fersino S; Giaj Levra N; Naccarato S; Sicignano G; Albanese S; Di Paola G; Alterio D; Ruggieri R; Alongi F
    Br J Radiol; 2014 Dec; 87(1044):20140543. PubMed ID: 25348370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy.
    Li B; Li D; Lau DH; Farwell DG; Luu Q; Rocke DM; Newman K; Courquin J; Purdy JA; Chen AM
    Radiat Oncol; 2009 Nov; 4():52. PubMed ID: 19909531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-Associated Chronic Dysphagia Assessment by Flexible Endoscopic Evaluation of Swallowing (FEES) in Head and Neck Cancer Patients: Swallowing-Related Structures and Radiation Dose-Volume Effect.
    Ozkaya Akagunduz O; Eyigor S; Kirakli E; Tavlayan E; Erdogan Cetin Z; Kara G; Esassolak M
    Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):73-84. PubMed ID: 30343589
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer.
    Chen AM; Li BQ; Lau DH; Farwell DG; Luu Q; Stuart K; Newman K; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1026-32. PubMed ID: 20231073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
    Webster GJ; Rowbottom CG; Ho KF; Slevin NJ; Mackay RI
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):617-22. PubMed ID: 18793966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
    Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
    Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
    Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DVH- and NTCP-based dosimetric comparison of different longitudinal margins for VMAT-IMRT of esophageal cancer.
    Münch S; Oechsner M; Combs SE; Habermehl D
    Radiat Oncol; 2017 Aug; 12(1):128. PubMed ID: 28806990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.